Cell-free DNA testing in the maternal blood in high-risk pregnancies after first-trimester combined screening

Abstract

In high-risk pregnancies after combined screening, a policy of selecting a subgroup for invasive testing and another for cfDNA testing would substantially reduce the number of invasive procedures and retain the ability to diagnose most of the observed aneuploidies.